Guilin Sanjin Pharmaceutical Co.,Ltd.’s Net Profit Rose 22.5% in First Half of 2022

Guilin Sanjin Pharmaceutical Co.,Ltd. (桂林三金药业股份有限公司) (002275.SZ) reported a net profit of 302.9 million yuan in the first half of 2022, up 22.5% year-on-year.

Meanwhile, the company posted 1 billion yuan in revenue, up 13.1% year-on-year.

At the end of the reporting period, it had 4.1 billion yuan in total assets and 1.2 billion yuan in total liabilities, with a liability-to-asset ratio of 29.3%.